Clinical Trials Logo

Chronic Obstructive Pulmonary clinical trials

View clinical trials related to Chronic Obstructive Pulmonary.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03197909 Completed - Clinical trials for Chronic Obstructive Pulmonary

Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study

Start date: July 6, 2017
Phase:
Study type: Observational

Chronic Obstructive Pulmonary Patients is a defined by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. It is associated with an atrophy of the skeletal muscle that impairs the patient's prognosis. The biological mechanisms of this muscle atrophy have not been elucidated, and the "spill-over theory" has recently emerged. Indeed, in COPD patients, the pulmonary inflammation is associated with a systemic low-grade inflammation, and the increased pro-inflamatory molelcules in the blood - which constitute the cellular micro-environement of the muscle fibre - could activate the mechanisms of the cell atrophy.

NCT ID: NCT00105183 Completed - Cystic Fibrosis Clinical Trials

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Start date: January 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of the study drug, known as "ATG Fresenius S," which is sometimes called "EZ-2053," to prevent a lung transplant patient's body from rejecting a transplanted lung or lungs.